BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35339459)

  • 1. Implementation of a Video-based Remote Germline Testing for Individuals With Pancreatic Ductal Adenocarcinoma.
    Kasliwal S; Baydogan S; Harrison D; Mork M; Maitra A; Mcallister F
    Gastroenterology; 2022 Jul; 163(1):316-318.e1. PubMed ID: 35339459
    [No Abstract]   [Full Text] [Related]  

  • 2. The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.
    Mohindroo C; De Jesus-Acosta A; Yurgelun MB; Maitra A; Mork M; McAllister F
    Surg Pathol Clin; 2022 Sep; 15(3):491-502. PubMed ID: 36049831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors.
    Chittenden A; Haraldsdottir S; Chen E; Nissim S
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):943-960. PubMed ID: 36265992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual dMMR Phenotype Locally Advanced Pancreatic Ductal Adenocarcinoma with Germline and Somatic BRCA2 Mutation in a Jehovah Witness Patient.
    Copur MS; Tun SM; Vargas L; Merani S; Wedel W; Duckert R; Horn A; Lintel N; Herold D; Lavudi S
    Clin Colorectal Cancer; 2023 Mar; 22(1):160-165. PubMed ID: 36404245
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in
    Saldia A; Olson SH; Nunes P; Liang X; Samson ML; Salo-Mullen E; Marcell V; Stadler ZK; Allen PJ; Offit K; Kurtz RC
    Cancer Prev Res (Phila); 2019 Sep; 12(9):599-608. PubMed ID: 31337648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutation.
    Okada K; Uemura K; Okamoto W; Sumiyoshi T; Shintakuya R; Otsuka H; Serikawa M; Ishii Y; Arihiro K; Takahashi S
    Clin J Gastroenterol; 2023 Apr; 16(2):283-288. PubMed ID: 36574187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
    Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
    Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
    Walker EJ; Carnevale J; Pedley C; Blanco A; Chan S; Collisson EA; Tempero MA; Ko AH
    Fam Cancer; 2019 Apr; 18(2):241-251. PubMed ID: 30267352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly growing pancreatic ductal adenocarcinoma in a patient with metastatic melanoma and harbouring CDKN2A germline mutation: a new vemurafenib-induced malignancy?
    Lipowicz S; Chagnon S; Saiag P
    Melanoma Res; 2013 Jun; 23(3):241. PubMed ID: 23624369
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of pancreatic ductal adenocarcinoma associated with carriage of BRCA1 and/or BRCA2 mutation: A systematic review and meta-analysis.
    McGarry JL; Creavin B; Kelly ME; Gallagher TK
    J Surg Oncol; 2022 Nov; 126(6):1028-1037. PubMed ID: 35770919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatch-repair-deficient metastatic pancreatic ductal adenocarcinoma with a germline PALB2 mutation: unusual genetics, unusual clinical course.
    Boeck S; Mehraein Y; Ormanns S; Kruger S; Westphalen CB; Haas M; Jung A; Kirchner T; Heinemann V
    Ann Oncol; 2017 Feb; 28(2):438-439. PubMed ID: 27803004
    [No Abstract]   [Full Text] [Related]  

  • 12. Germline Testing for Individuals With Pancreatic Cancer: The Benefits and Challenges to Casting a Wider Net.
    Yurgelun MB
    J Clin Oncol; 2017 Oct; 35(30):3375-3377. PubMed ID: 28834438
    [No Abstract]   [Full Text] [Related]  

  • 13. Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinoma.
    Peters MLB; Stobie L; Dudley B; Karloski E; Allen K; Speare V; Dolinsky JS; Tian Y; DeLeonardis K; Krejdovsky J; Button A; Lim C; Borazanci E; Brand R; Tung N
    Cancer; 2019 Jul; 125(14):2488-2496. PubMed ID: 30980401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
    Holter S; Borgida A; Dodd A; Grant R; Semotiuk K; Hedley D; Dhani N; Narod S; Akbari M; Moore M; Gallinger S
    J Clin Oncol; 2015 Oct; 33(28):3124-9. PubMed ID: 25940717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pancreatic ductal adenocarcinoma].
    Gallmeier E; Gress TM
    Internist (Berl); 2018 Aug; 59(8):805-822. PubMed ID: 29980819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
    Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N
    Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report.
    Ottenhof NA; de Wilde RF; Morsink FH; de Leng WW; Ausems MG; Morreau H; van Hillegersberg R; Offerhaus GJ; Milne AN
    Hum Pathol; 2012 Mar; 43(3):457-61. PubMed ID: 21992816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?
    Liu DSK; Mato Prado M; Giovannetti E; Jiao LR; Krell J; Frampton AE
    Expert Rev Mol Diagn; 2019 Jul; 19(7):553-558. PubMed ID: 31159604
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation.
    Uemura S; Matsubayashi H; Kiyozumi Y; Uesaka K; Yamamoto Y; Sasaki K; Abe M; Urakami K; Kusuhara M; Yamaguchi K
    Fam Cancer; 2018 Apr; 17(2):255-259. PubMed ID: 28755079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?
    Connor AA; Gallinger S
    Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):683-694. PubMed ID: 28460572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.